Suprobion Medsp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-11-19
Share capital
5,000.00 PLN
Registered address
Kiełczowska 2, 55-095 Mirków, Poland
Website
suprobion.com
Electronic delivery address
AE:PL-77573-14872-EVUFD-24

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$23,616

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 157 days for 2022).

  • 202513/08/2026
  • 202410/07/2025
  • 202317/07/2024
  • 202219/12/2023
  • 202131/10/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of basic pharmaceutical products21 / 46
Top 46%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations139 / 231
Top 60%
Sector · Manufacturing15,924 / 24,467
Top 65%
Voivodeship · Dolnośląskie10,472 / 23,907
Top 44%
Country · Poland133,874 / 297,932
Top 45%

Results vs industry

Revenue
This companyUSD 395.88kMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 69.85kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 302.41kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 350.95kMedianUSD 118.27kAverageUSD 1.54m

Industry

Offer

  • Cronos strain
  • Jelly Punch strain
  • Lemon Jazz strain
  • Magic Power strain
  • Papaya Bomb strain
  • Purple Cookie strain
  • Soho strain

Authorized Representatives

Jarosław Sadłekage 63 – Attorney-in-fact (sole)
Wojciech Józef Sadłekage 59 – President of the Management Board

Manner of representation

If the company has a one-person management board, the President of the Management Board or a commercial proxy is authorized independently to make declarations of will on behalf of the company. If the management board is a multi-member management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Jarosław Sadłekage 63
25$675.3150%
Wojciech Józef Sadłekage 59
25$675.3150%

Jarosław Sadłek and Wojciech Józef Sadłek hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
TAK Pharmasp. z o.o.
Alpha Pharmaceuticalsp. z o.o.
Natur DayS.A.
Biotriosp. z o.o.
Inner Harmonysp. z o.o.
Biocanto Pharmasp. z o.o.
Nature's Voicesp. z o.o.
Vilowaysp. z o.o.
DR Herbichsp. z o.o.
Rohto-Mentholatum Europesp. z o.o.

Change history

DateEvent
2024-06-20Name change
2023-04-14PKD change
2013-11-19Entered in the register

FAQ

Last updated: 2026-08-13